Whalesbook
India Advances in Multi-Omics Research
Strand Life Sciences, part of Reliance Industries, is positioning India at the forefront of multi-omics research with its new Olink Explore HT proteomics service. This advancement directly contributes to the growing proteomics market by integrating genomics and bioinformatics, offering a comprehensive approach to understanding complex diseases and speeding up the development of targeted therapies.
Proteomics Market Growth in India
The Indian proteomics market is set for strong expansion, with forecasts predicting a compound annual growth rate (CAGR) of 7.98% between 2026 and 2034. The market is expected to reach USD 2,934.5 million by 2034. Key drivers include rising cancer rates, the need for early and precise diagnostics, and technological progress in areas like liquid biopsies and AI for discovery. Globally, the proteomics market is also growing, projected to hit USD 93.48 billion by 2034, with the Asia Pacific region leading the expansion.
Reliance Industries' Strategic Moves
Reliance Industries Limited, a major Indian conglomerate, is strategically expanding into advanced technology sectors with its investment in proteomics via Strand Life Sciences. The company's financial standing is robust, with a market capitalization of INR 17.89 trillion and a P/E ratio of 22.16 as of May 19, 2026. Reliance's credit rating was recently upgraded to 'A-' by S&P Global, reflecting improved cash flow stability from its digital services and retail businesses.
Olink Technology and Thermo Fisher Acquisition
The Olink Explore HT technology used by Strand Life Sciences is from Olink Holding AB, which has a market capitalization of around $3.25 billion. Olink has faced recent net losses and has a negative P/E ratio. Olink was acquired by Thermo Fisher Scientific for approximately $3.1 billion, a move that signals market consolidation and strong interest in Olink's high-throughput proteomics capabilities. This integration allows Thermo Fisher to enhance its existing life sciences platforms.
Competitive Landscape in Proteomics
Key competitors in the proteomics market include Quanterix, MSD, and Luminex. Major players like Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are actively investing in advanced analytical platforms and AI tools to drive innovation in this field.
Financial Outlook for Olink
Despite the market opportunities, Olink Holding AB faces financial challenges. The company reported a net loss of $(16.1) million in Q1 2024 and has a negative P/E ratio. As a subsidiary of Thermo Fisher Scientific, Olink's future strategy and growth will be guided by its parent company's objectives. Analysts currently maintain a consensus 'Hold' rating on Olink, with target prices showing little upside potential.
Future Potential for India's Biotech Sector
The introduction of advanced proteomics services by Reliance's Strand Life Sciences is expected to significantly boost India's biotechnology and precision medicine sectors. The projected growth of the Indian proteomics market, combined with global advances in multi-omics, points to a strong future for companies utilizing these technologies. The increasing demand for personalized medicine and early disease detection will continue to drive innovation and investment, reinforcing India's role in global life sciences research.